Steven Gannon, Director at Fusion Pharmaceuticals Inc. (FUSN), bought 3,171 shares at $8.05 ($26K) on 2021-08-18, disclosed to the SEC on 2021-08-20.
Open-market purchase of $26k FUSN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.05 | 171 | $1K | 5.4% |
| 2 | $8.05 | 3,000 | $24K | 94.6% |
| Total | $8.05 avg | 3,171 | $26K | 100% |
| Filing → |
| XENE | SELL | 2024-03-08 | $602K | — | Filing → |
| FUSN | BUY | 2022-08-11 | $180K | — | Filing → |
| FUSN | BUY | 2021-08-23 | $23K | — | Filing → |